Holen Sie sich die Stockscreener-App
22.44
5.45%
1.16
Nanobiotix Adr Aktie (NBTX) Neueste Nachrichten
NBTX Q2 2026 Earnings: Wider-Than-Expected Loss Sends Shares Down 7.71%Earnings Volatility Report - https://www.dars.gov.et/
Head and Neck Squamous Cell Carcinoma (HNSCC)Market Insights, Epidemiology, and Market Forecast2036 | Set to Reach $2.56 Billion as HPV-Targeted Vaccines Reshape Care - GlobeNewswire Inc.
NBTX Edges Lower: Nanobiotix Holds Near $33 as Traders Eye $31.64 SupportRelative Volume - https://www.siam.in/
NBTX Edges Lower: Nanobiotix Holds Near $33 as Traders Eye $31.64 SupportTriangle Correction - dars.gov.et
NBTX Q4 2025 Earnings: Loss per Share of -0.39 Comes In Below Consensus EstimateAnnual Earnings Summary - www.dars.gov.et
NBTX Q4 2025 Earnings: Loss per Share of -0.39 Comes In Below Consensus EstimatePre-Announcement Alert - www.dars.gov.et
NBTX Q4 2025 Earnings: Loss per Share of -0.39 Comes In Below Consensus EstimateRevenue Miss Report - dars.gov.et
NBTX Q4 2025 Earnings: Loss per Share of -0.39 Comes In Below Consensus EstimateAnnual Financial Report - dars.gov.et
Stevanato Group S.p.A. (STVN) Stock Price & News - Syfe
Sirius XM, Dell, Ollie's Bargain Outlet And Other Big Stocks Moving Higher On Wednesday - Benzinga
NBTX Q4 2025 Earnings: $0.39 Per-ADS Loss Misses Estimate by 170.16%, Yet Shares Gain 5.17%Buyback Announcement Report - dars.gov.et
NBTX Q4 2025 Earnings: $0.39 Per-ADS Loss Misses Estimate by 170.16%, Yet Shares Gain 5.17%Subscription Growth Report - careplusvn.com
NBTX Q4 2025 Earnings: $0.39 Per-ADS Loss Misses Estimate by 170.16%, Yet Shares Gain 5.17%Positive Surprise Momentum - www.dars.gov.et
Biophytis (BPTS) Peer Comparison – Compare with Others - valueresearchonline.com
Nanobiotix (NBTX) Results Breakdown: EPS Comes in Below Forecast in the Reported Period; Closing Move: The Stock Loses 0.30%Earnings Whisper Number - careplusvn.com
Nanobiotix (NBTX) Results Breakdown: EPS Comes in Below Forecast in the Reported Period; Closing Move: The Stock Loses 0.30%Growth Acceleration Report - dars.gov.et
Nanobiotix (NBTX) Results Breakdown: EPS Comes in Below Forecast in the Reported Period; Closing Move: The Stock Loses 0.30%Final Results - www.dars.gov.et
Nanobiotix (NBTX) Results Breakdown: EPS Comes in Below Forecast in the Reported Period; Closing Move: The Stock Loses 0.30%Healthcare Earnings Report - dars.gov.et
Nanobiotix (NBTX) Q4 2025 Filing Snapshot: EPS Does Not Reach the Reported Estimate under the Current Snapshot; Post-Earnings Trading: The Stock Records a 3.23% DecreaseDownward Estimate Revision - dars.gov.et
Nanobiotix (NBTX) Q4 2025 Filing Snapshot: EPS Does Not Reach the Reported Estimate under the Current Snapshot; Post-Earnings Trading: The Stock Records a 3.23% DecreaseFinancial Data - www.dars.gov.et
NBTX Q4 2025 Earnings: Clinical-Stage Burn and a Wide EPS MissROE Trend Analysis - careplusvn.com
NBTX Q4 2025 Earnings: Clinical-Stage Burn and a Wide EPS MissSubscription Growth Report - dars.gov.et
Nanobiotix (NASDAQ:NBTX) Sees Large Volume IncreaseTime to Buy? - MarketBeat
Nanobiotix S.A. (NBTX) investor group reports 9.4% stake and pre-funded warrants - Stock Titan
Nanobiotix (NBTX) Advances 2.63% to $39.74 as Oncology Pipeline Draws InterestForce Index - dars.gov.et
Nanobiotix (NBTX) Advances 2.63% to $39.74 as Oncology Pipeline Draws InterestMedian Line - dars.gov.et
Nanobiotix (NBTX) Advances 2.63% to $39.74 as Oncology Pipeline Draws InterestSwing Trade Setups - www.dars.gov.et
Nanobiotix (NASDAQ:NBTX) Shares Gap UpHere's What Happened - MarketBeat
Nanobiotix (NBTX) Q4 2025 Earnings: Missed EPS Estimate by Wide Margin as Stock SlipsConsensus Beat Rate - careplusvn.com
Nanobiotix S.A.Sponsored ADR (NASDAQ:NBTX) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Nanobiotix (NBTX) Q4 2025 Earnings: Missed EPS Estimate by Wide Margin as Stock SlipsMid-Term Outlook - dars.gov.et
Qatar Investment Authority (NBTX) reports 3.53M Nanobiotix ADRs under sole control - Stock Titan
Nanobiotix (NASDAQ:NBTX) Stock Price Down 5.4%What's Next? - MarketBeat
Nanobiotix (NBTX) Faces Selling Pressure: Approaching Key Support After 4% DeclineVWAP Bounce - careplusvn.com
Nanobiotix (NBTX) Faces Selling Pressure: Approaching Key Support After 4% DeclineFRAMA Signal - dars.gov.et
SK hynix Inc. American Depositary Shares (SKHY) Historical Data - Nasdaq
NBTXNanobiotix ADR Dividends - Finviz
5NRA Forecast — Price Target — Prediction for 2027 - TradingView
5NRA Forecast — Price Target — Prediction for 2027 - TradingView
NBTX Stock Price, Quote & Chart - ChartMill
NBTXNanobiotix ADR Options - Finviz
NANOBIOTIX Announces Closing of Global Offering - GlobeNewswire Inc.
NBTX - Finviz
NANOBIOTIX Announces Closing of Global Offering - GlobeNewswire
NANOBIOTIX Announces Closing of Global Offering - Finansavisen
NANOBIOTIX Announces Closing of Global Offering - GlobeNewswire
Nanobiotix Announces Pricing of Oversubscribed €85m Global Offering - GlobeNewswire Inc.
Nanobiotix Announces Temporary Trading Halt of Its Ordinary Shares on Euronext Paris - Yahoo Finance UK
Nanobiotix Announces Temporary Trading Halt of Its Ordinary Shares on Euronext Paris - Barchart.com
Nanobiotix: Trading Halt on Euronext Paris for a Global Securities Offering - ideal-investisseur.fr
3.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):